<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04038814</url>
  </required_header>
  <id_info>
    <org_study_id>AFMKrakowU</org_study_id>
    <nct_id>NCT04038814</nct_id>
  </id_info>
  <brief_title>The Effectiveness of the Modified Bundle in the Prevention of VAP.</brief_title>
  <acronym>VAP</acronym>
  <official_title>The Effectiveness of the Modified Bundle in the Prevention of Ventilator-associated Pneumonia in Adult Patients in the Intensive Care Unit.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Andrzej Frycz Modrzewski Krakow University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Andrzej Frycz Modrzewski Krakow University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator-associated pneumonia (VAP) is an important cause of prolonged intensive care unit
      and hospital length of stay, healthcare costs and mortality in mechanically ventilated
      patients. There are an international guidelines for VAP diagnosis, treatment and prevention
      (Infectious Diseases Society of America(IDSA)/American Thoracic Society (ATS) 2016 and
      European Respiratory Society (ERS) / European Society of Intensive Care Medicine (ESICM) /
      European Society of Clinical Microbiology and Infectiuos Diseases (ESCMID) / Asociacion
      Latinoamericana del Torax (ALAT) 2017) routinely used in most ICUs. The investigator planed
      on comparing two strategies for prevention of VAP in mechanically ventilated patients: the
      routine VAP bundle ( historical group - VAP1) and the modified VAP bundle ( study group -
      VAP2) by using 3 modifications ( Shiley Evac Endotracheal tube with TaperGuard Cuff,
      Automatic continuous subglottic secretion drainage (SSD) and continuous tube cuff pressure
      monitoring).

      The aim of the study is an assessment of the effectiveness of the modified prevention of VAP
      in reduction of: early and late VAP cases, mechanical ventilation days (MV), length of stay
      (LOS) in the ICU, 28 day mortality and multi drug resistent pathogens (MDR) cases in adult
      ICU patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">July 15, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Early VAP</measure>
    <time_frame>day: 2 - 5 of mechanical ventilation</time_frame>
    <description>Total VAP cases in the ICU ( CEPPIS /Chest Echocardiography and Procalcitonin Pulmonary Infection Score/ criteria ) with early beginning of the pneumonia symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Late VAP</measure>
    <time_frame>day: 6 - the last day in ICU</time_frame>
    <description>total VAP cases in the ICU ( CEPPIS criteria ) with late beginning of the pneumonia symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>LOS</measure>
    <time_frame>day: 1 - the last day in the ICU, but at least 2 days</time_frame>
    <description>lenght of stay in the ICU (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MV</measure>
    <time_frame>day: 1 - the last day in the ICU, but at least 2 days</time_frame>
    <description>Duration of mechanical ventilation (days) in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nonMV</measure>
    <time_frame>day: 1 - the last day in the ICU,</time_frame>
    <description>Total non mechanical ventilation days in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>day: 1 - 28</time_frame>
    <description>Mortality of adult mechanically ventilated patients in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MDR</measure>
    <time_frame>day: 1 - the last day in the ICU,</time_frame>
    <description>Number of cases with multi drug resistant (MDR) pathogens detected in specimens of mucus taken from the lower airways in mechanically ventilated patients in the ICU.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">386</enrollment>
  <condition>VAP - Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>VAP1 - historical group</arm_group_label>
    <description>Routine prevention of VAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VAP2 - study group</arm_group_label>
    <description>Modified prevention of VAP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Routine prevention of VAP</intervention_name>
    <description>Enhanced hand hygiene protocol, tube cuff pressure monitoring ( set on 25-30 mm Hg) every 12 hours and every time when we suspected under or over distention, fast withdrawal of sedation, moderate supportive mechanical ventilation ( tidal volume (VT) 5-8 ml/kg ideal body weight (IBW), positive end expiratory pressure (PEEP) 3-5 cmH2O, Plateau pressure (Ppl) &lt; 25 cm H2O, normocapnia ), Proton Pump Inhibitors (PPIs) reduction, Selective oral decontamination (SOD) every 8 hours - 0,2% chlorhexidine digluconate mouthwash, Closed Tracheal Suction System (CTSS) - changed every 7 day, 30-45% lifting of the thorax</description>
    <arm_group_label>VAP1 - historical group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified prevention of VAP</intervention_name>
    <description>3 modifications of the routine bundle in the prevention of VAP:
Endotracheal tube ( Shiley Evac Endotracheal tube with TaperGuard Cuff) and tracheostomy tubes (Tracheostomy Tube Cuffed Seal Guard) instead of regular tubes,
Automatic, continuous tube cuff pressure monitoring ( Covidien Shiley M Pressure Control Automatic Cuff Controller ( 25-30 mmHg),
Automatic continuous subglottic secretion drainage</description>
    <arm_group_label>VAP2 - study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study group were male and female patients ( neurosurgical, cardiological, general
        surgical and non cardiological internal medicine type) in adult ICU. Each enrolled patient
        was mechanically ventilated for a period longer than 48 hours.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        VAP2 - study group

          -  mechanically ventilated patients with an artificial airways (endotracheal tube,
             tracheostomy tube)

          -  age over 18 years

          -  modified bundle in the prevention of VAP

        VAP1 - historical group

          -  mechanically ventilated patients with an artificial airways (endotracheal tube,
             tracheostomy tube)

          -  patients hospitalised in the ICU for last 12 months before modified bundle in the
             prevention of VAP has been started (from 01.05.2017 to 30.04.2018)

          -  age over 18 years

          -  routine bundle in the prevention of VAP

        Exclusion Criteria:

          -  lack of an informed consent in awake patients in the ICU

          -  age under 18 years

          -  patients with no mechanical ventilation in the ICU

          -  patients with probability of mechanical ventilation days and LOS in the ICU less than
             48 hours

          -  patients intubated and mechanically ventilated without the bundle in the prevention of
             VAP for a period of time longer than 12 hours before the admission to the ICU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JAROSLAW PAWLIK, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Andrzej Frycz Modrzewski Krakow University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anaesthesiology and Intensive Care Unit St. Raphael Hospital</name>
      <address>
        <city>Kraków</city>
        <state>Małopolska</state>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 27, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>July 29, 2019</last_update_submitted>
  <last_update_submitted_qc>July 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Andrzej Frycz Modrzewski Krakow University</investigator_affiliation>
    <investigator_full_name>JAROSLAW PAWLIK</investigator_full_name>
    <investigator_title>MD, Specialist of anaesthesiology and intensive care, An assistant of The Faculty of Medicine and Health Sciences</investigator_title>
  </responsible_party>
  <keyword>VAP</keyword>
  <keyword>Evac Endotracheal Tube with TaperGuard Cuff</keyword>
  <keyword>MDR - multi drug resistant pathogens</keyword>
  <keyword>SSD - subglottic secretion drainage,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

